Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cibus (CBUS) Total Non-Current Liabilities (2016 - 2025)

Cibus' Total Non-Current Liabilities history spans 9 years, with the latest figure at $245.3 million for Q3 2024.

  • For Q3 2024, Total Non-Current Liabilities changed N/A year-over-year to $245.3 million; the TTM value through Sep 2024 reached $245.3 million, changed N/A, while the annual FY2023 figure was $204.2 million, 1244.81% up from the prior year.
  • Total Non-Current Liabilities for Q3 2024 was $245.3 million at Cibus, roughly flat from $244.6 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $245.3 million in Q3 2024 and bottomed at $15.2 million in Q4 2022.
  • The 5-year median for Total Non-Current Liabilities is $24.6 million (2020), against an average of $73.2 million.
  • The largest annual shift saw Total Non-Current Liabilities tumbled 32.08% in 2022 before it surged 1244.81% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $26.3 million in 2020, then fell by 15.11% to $22.4 million in 2021, then crashed by 32.08% to $15.2 million in 2022, then soared by 1244.81% to $204.2 million in 2023, then rose by 20.08% to $245.3 million in 2024.
  • Per Business Quant, the three most recent readings for CBUS's Total Non-Current Liabilities are $245.3 million (Q3 2024), $244.6 million (Q2 2024), and $211.5 million (Q1 2024).